Tobacco use remains the leading cause of disease and death in the U.S. And it causes more than 480,000 deaths every single year. In addition to the devastating human toll caused by cigarette smoking, tobacco also causes substantial financial costs to society. Every year, direct health care and lost productivity costs totaling nearly $300 billion. “Addition to cigarettes can cause overwhelming amount of death and disease. Unless we change course, 5.6 million young people alive today will die prematurely,” said a FDA commissioner.
FDA is an agency within the U.S. Department of Health and Human Services. It promotes and protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. It also is responsible for the safety and security of the nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
According to the news & events from the U.S. Food & Drug Administration, to reduce tobacco-related disease and death, the FDA announced a new comprehensive plan for tobacco and nicotine regulation.
The regulation will serve as a multi-year roadmap. The approach places nicotine and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal is to ensure the FDA has the proper foundation to implement the Family Smoking Prevention and Tobacco Control Act. To make certain the FDA is striking a balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes, the agency is also providing targeted relief on some timelines described in the May 2016 final rule that extended the FDA’s authority to additional tobacco products.
The FDA is encouraging innovations to make a notable public health difference and inform policies and efforts that will best protect kids and help smokers quit cigarettes.
To make this effort successful, the agency intends to extend timelines to submit tobacco product review applications for newly-regulated tobacco products that were on the market as of Aug. 8, 2016.
The agency plans to issue this guidance describing a new enforcement policy shortly. Under expected revised timelines, applications for newly-regulated combustible products. For example, pipe tobacco and hookah tobacco, would be submitted by Aug. 8, 2021. And applications for non-combustible products such as ENDS or e-cigarettes would be submitted by Aug. 8, 2022. Additionally, the FDA expects that manufacturers would continue to market products while the agency reviews product applications.
Ryan is a writer, editor and content creator who spends most of his time bringing the interesting, entertaining, original and well-written articles to vapers. He believes that vaping is not only a healthier alternative to smoking, but also a great experience of life.